Hainan Huluwa Pharmaceutical Group Co. Ltd.SSE: 605199

Announcement on Abnormal Fluctuations in Stock Trading

Jan 1, 2026 · Issued by Hainan Huluwa Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 1, 2026

On 6ix: 6ix.com/news/announcement-on-abnormal-fluctuations-in-stock-trading-933

Announcement on Abnormal Fluctuations in Stock Trading

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Hainan Huluwa Pharmaceutical

Announcement on Receiving Notice of Case Filing from China Securities Regulatory CommissionDec 29, 2025
Notice on Convening the 3rd Extraordinary General Meeting in 2025Dec 16, 2025
Announcement on Judicial Freezing of Some Shares of Controlling ShareholderDec 6, 2025
Announcement on Providing Guarantee for Wholly-owned SubsidiaryDec 2, 2025
Announcement on Progress in Signing of Technology Cooperation Contract with a Related Party and Related Party TransactionNov 1, 2025

Later from Hainan Huluwa Pharmaceutical

Announcement on Obtaining Drug Registration Certificate for Levosalbutamol Hydrochloride Nebuliser SolutionJan 6
Indicative Announcement on Upcoming Judicial Auction of Some Shares Held by Controlling ShareholderJan 21
Announcement on Providing Guarantee for Wholly-owned Subsidiary by Guangxi Weiwei Pharmaceutical Co., Ltd.Jan 30
Announcement on Expected Loss in Performance for 2025Jan 31
Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral SolutionFeb 7

All Hainan Huluwa Pharmaceutical news releases

Follow Hainan Huluwa Pharmaceutical into a list and get an email when it puts out news.

Follow Hainan Huluwa Pharmaceutical